Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
67
XBI Quote, Financials, Valuation and Earnings
Last price:
$124.18
Seasonality move
:
-1.93%
Day range:
$123.64 - $125.68
52-week range:
$66.66 - $129.12
Dividend yield:
0.36%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
9.8M
Avg. volume:
9.2M
1-year change:
41.29%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | -- | -- | -- | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- |
|
XHS
State Street SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XBI
State Street SPDR S&P Biotech ETF
|
$124.18 | -- | -- | -- | $0.41 | 0.36% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$211.36 | -- | -- | -- | $1.17 | 0% | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
$74.76 | -- | -- | -- | $0.27 | 1.39% | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
$89.57 | -- | -- | -- | $0.02 | 0.08% | -- |
|
XHS
State Street SPDR S&P Health Care Services ETF
|
$110.08 | -- | -- | -- | $0.12 | 0.26% | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
$155.74 | -- | -- | -- | $0.66 | 1.59% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | 0.938 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 0.539 | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | 0.179 | -- | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
-- | 0.957 | -- | -- |
|
XHS
State Street SPDR S&P Health Care Services ETF
|
-- | 0.719 | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | 0.034 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | -- | -- | -- | -- | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- | -- |
|
XHS
State Street SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -- | -- | -- | -- | -- |
State Street SPDR S&P Biotech ETF vs. Competitors
-
Which has Higher Returns XBI or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to State Street SPDR S&P Biotech ETF's net margin of --. State Street SPDR S&P Biotech ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBIState Street SPDR S&P Biotech ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About XBI or FBT?
State Street SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Biotech ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe State Street SPDR S&P Biotech ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings XBIState Street SPDR S&P Biotech ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is XBI or FBT More Risky?
State Street SPDR S&P Biotech ETF has a beta of 0.922, which suggesting that the stock is 7.765% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.721, suggesting its less volatile than the S&P 500 by 27.892%.
-
Which is a Better Dividend Stock XBI or FBT?
State Street SPDR S&P Biotech ETF has a quarterly dividend of $0.41 per share corresponding to a yield of 0.36%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0% to investors and pays a quarterly dividend of $1.17 per share. State Street SPDR S&P Biotech ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or FBT?
State Street SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. State Street SPDR S&P Biotech ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, State Street SPDR S&P Biotech ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Biotech ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBIState Street SPDR S&P Biotech ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns XBI or FHLC?
Fidelity MSCI Health Care Index ETF has a net margin of -- compared to State Street SPDR S&P Biotech ETF's net margin of --. State Street SPDR S&P Biotech ETF's return on equity of -- beat Fidelity MSCI Health Care Index ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBIState Street SPDR S&P Biotech ETF-- -- -- FHLCFidelity MSCI Health Care Index ETF-- -- -- -
What do Analysts Say About XBI or FHLC?
State Street SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Fidelity MSCI Health Care Index ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Biotech ETF has higher upside potential than Fidelity MSCI Health Care Index ETF, analysts believe State Street SPDR S&P Biotech ETF is more attractive than Fidelity MSCI Health Care Index ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBIState Street SPDR S&P Biotech ETF0 0 0 FHLCFidelity MSCI Health Care Index ETF0 0 0 -
Is XBI or FHLC More Risky?
State Street SPDR S&P Biotech ETF has a beta of 0.922, which suggesting that the stock is 7.765% less volatile than S&P 500. In comparison Fidelity MSCI Health Care Index ETF has a beta of 0.691, suggesting its less volatile than the S&P 500 by 30.944%.
-
Which is a Better Dividend Stock XBI or FHLC?
State Street SPDR S&P Biotech ETF has a quarterly dividend of $0.41 per share corresponding to a yield of 0.36%. Fidelity MSCI Health Care Index ETF offers a yield of 1.39% to investors and pays a quarterly dividend of $0.27 per share. State Street SPDR S&P Biotech ETF pays -- of its earnings as a dividend. Fidelity MSCI Health Care Index ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or FHLC?
State Street SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than Fidelity MSCI Health Care Index ETF quarterly revenues of --. State Street SPDR S&P Biotech ETF's net income of -- is lower than Fidelity MSCI Health Care Index ETF's net income of --. Notably, State Street SPDR S&P Biotech ETF's price-to-earnings ratio is -- while Fidelity MSCI Health Care Index ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Biotech ETF is -- versus -- for Fidelity MSCI Health Care Index ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBIState Street SPDR S&P Biotech ETF-- -- -- -- FHLCFidelity MSCI Health Care Index ETF-- -- -- --
-
Which has Higher Returns XBI or XHE?
State Street SPDR S&P Health Care Equipment ETF has a net margin of -- compared to State Street SPDR S&P Biotech ETF's net margin of --. State Street SPDR S&P Biotech ETF's return on equity of -- beat State Street SPDR S&P Health Care Equipment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBIState Street SPDR S&P Biotech ETF-- -- -- XHEState Street SPDR S&P Health Care Equipment ETF-- -- -- -
What do Analysts Say About XBI or XHE?
State Street SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P Health Care Equipment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Biotech ETF has higher upside potential than State Street SPDR S&P Health Care Equipment ETF, analysts believe State Street SPDR S&P Biotech ETF is more attractive than State Street SPDR S&P Health Care Equipment ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBIState Street SPDR S&P Biotech ETF0 0 0 XHEState Street SPDR S&P Health Care Equipment ETF0 0 0 -
Is XBI or XHE More Risky?
State Street SPDR S&P Biotech ETF has a beta of 0.922, which suggesting that the stock is 7.765% less volatile than S&P 500. In comparison State Street SPDR S&P Health Care Equipment ETF has a beta of 1.113, suggesting its more volatile than the S&P 500 by 11.281%.
-
Which is a Better Dividend Stock XBI or XHE?
State Street SPDR S&P Biotech ETF has a quarterly dividend of $0.41 per share corresponding to a yield of 0.36%. State Street SPDR S&P Health Care Equipment ETF offers a yield of 0.08% to investors and pays a quarterly dividend of $0.02 per share. State Street SPDR S&P Biotech ETF pays -- of its earnings as a dividend. State Street SPDR S&P Health Care Equipment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or XHE?
State Street SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than State Street SPDR S&P Health Care Equipment ETF quarterly revenues of --. State Street SPDR S&P Biotech ETF's net income of -- is lower than State Street SPDR S&P Health Care Equipment ETF's net income of --. Notably, State Street SPDR S&P Biotech ETF's price-to-earnings ratio is -- while State Street SPDR S&P Health Care Equipment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Biotech ETF is -- versus -- for State Street SPDR S&P Health Care Equipment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBIState Street SPDR S&P Biotech ETF-- -- -- -- XHEState Street SPDR S&P Health Care Equipment ETF-- -- -- --
-
Which has Higher Returns XBI or XHS?
State Street SPDR S&P Health Care Services ETF has a net margin of -- compared to State Street SPDR S&P Biotech ETF's net margin of --. State Street SPDR S&P Biotech ETF's return on equity of -- beat State Street SPDR S&P Health Care Services ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBIState Street SPDR S&P Biotech ETF-- -- -- XHSState Street SPDR S&P Health Care Services ETF-- -- -- -
What do Analysts Say About XBI or XHS?
State Street SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P Health Care Services ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Biotech ETF has higher upside potential than State Street SPDR S&P Health Care Services ETF, analysts believe State Street SPDR S&P Biotech ETF is more attractive than State Street SPDR S&P Health Care Services ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBIState Street SPDR S&P Biotech ETF0 0 0 XHSState Street SPDR S&P Health Care Services ETF0 0 0 -
Is XBI or XHS More Risky?
State Street SPDR S&P Biotech ETF has a beta of 0.922, which suggesting that the stock is 7.765% less volatile than S&P 500. In comparison State Street SPDR S&P Health Care Services ETF has a beta of 1.014, suggesting its more volatile than the S&P 500 by 1.381%.
-
Which is a Better Dividend Stock XBI or XHS?
State Street SPDR S&P Biotech ETF has a quarterly dividend of $0.41 per share corresponding to a yield of 0.36%. State Street SPDR S&P Health Care Services ETF offers a yield of 0.26% to investors and pays a quarterly dividend of $0.12 per share. State Street SPDR S&P Biotech ETF pays -- of its earnings as a dividend. State Street SPDR S&P Health Care Services ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or XHS?
State Street SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than State Street SPDR S&P Health Care Services ETF quarterly revenues of --. State Street SPDR S&P Biotech ETF's net income of -- is lower than State Street SPDR S&P Health Care Services ETF's net income of --. Notably, State Street SPDR S&P Biotech ETF's price-to-earnings ratio is -- while State Street SPDR S&P Health Care Services ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Biotech ETF is -- versus -- for State Street SPDR S&P Health Care Services ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBIState Street SPDR S&P Biotech ETF-- -- -- -- XHSState Street SPDR S&P Health Care Services ETF-- -- -- --
-
Which has Higher Returns XBI or XLV?
State Street Health Care Select Sector SPDR ETF has a net margin of -- compared to State Street SPDR S&P Biotech ETF's net margin of --. State Street SPDR S&P Biotech ETF's return on equity of -- beat State Street Health Care Select Sector SPDR ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBIState Street SPDR S&P Biotech ETF-- -- -- XLVState Street Health Care Select Sector SPDR ETF-- -- -- -
What do Analysts Say About XBI or XLV?
State Street SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street Health Care Select Sector SPDR ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Biotech ETF has higher upside potential than State Street Health Care Select Sector SPDR ETF, analysts believe State Street SPDR S&P Biotech ETF is more attractive than State Street Health Care Select Sector SPDR ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBIState Street SPDR S&P Biotech ETF0 0 0 XLVState Street Health Care Select Sector SPDR ETF0 0 0 -
Is XBI or XLV More Risky?
State Street SPDR S&P Biotech ETF has a beta of 0.922, which suggesting that the stock is 7.765% less volatile than S&P 500. In comparison State Street Health Care Select Sector SPDR ETF has a beta of 0.653, suggesting its less volatile than the S&P 500 by 34.675%.
-
Which is a Better Dividend Stock XBI or XLV?
State Street SPDR S&P Biotech ETF has a quarterly dividend of $0.41 per share corresponding to a yield of 0.36%. State Street Health Care Select Sector SPDR ETF offers a yield of 1.59% to investors and pays a quarterly dividend of $0.66 per share. State Street SPDR S&P Biotech ETF pays -- of its earnings as a dividend. State Street Health Care Select Sector SPDR ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or XLV?
State Street SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than State Street Health Care Select Sector SPDR ETF quarterly revenues of --. State Street SPDR S&P Biotech ETF's net income of -- is lower than State Street Health Care Select Sector SPDR ETF's net income of --. Notably, State Street SPDR S&P Biotech ETF's price-to-earnings ratio is -- while State Street Health Care Select Sector SPDR ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Biotech ETF is -- versus -- for State Street Health Care Select Sector SPDR ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBIState Street SPDR S&P Biotech ETF-- -- -- -- XLVState Street Health Care Select Sector SPDR ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
